Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/5519
Title: Geissospermum vellosii stembark Anticholinesterase activity and improvement of scopolamine-induced memory deficits
Authors: Lima, Josélia Alencar
Costa, Rodrigo Saar da
Epifanio, Rosângela de Almeida
Castro, Newton Gonçalves de
Rocha, Monica Santos
Pinto, Angelo da Cunha
Keywords: Acetilcolinesterase
Acetylcholinesterase
Doença de Alzheimer
Alzheimer Disease
Butirilcolinesterase
Butyrylcholinesterase
Geissospermum
Escopolamina
Scopolamine
Teste do Labirinto Aquático de Morris
Morris Water Maze Test
Acetilcolinesterasa
Enfermedad de Alzheimer
Butirilcolinesterasa
Prueba del Laberinto Acuático de Morris
Issue Date: 2009
Publisher: Pharmacology, Biochemistry and Behavior
Citation: LIMA, Josélia Alencar et al. Geissospermum vellosii stembark Anticholinesterase activity and improvement of scopolamine-induced memory deficits. Pharmacology, Biochemistry and Behavior, v. 92, p. 508–513, 2009.
Abstract: This study evaluated the cholinesterase inhibitory activity of an alkaloid-rich fraction of stembark from Geissospermum vellosii (PP), and its effect on memory tests in mice. PP inhibited rat brain and electric eel acetylcholinesterase, as well as horse serum butyrylcholinesterase in a concentration-dependent manner with mean IC(50) values of 39.3 microg/mL, 2.9 microg/mL, and 1.6 microg/mL, respectively. The main alkaloid with anticholinesterase activity in PP was isolated and identified as geissospermine. PP significantly reduced scopolamine-induced amnesia in the passive avoidance and Morris water maze tests, at 30 mg/kg i.p. (given 45 min before the test sessions). At the highest effective dose (60 mg/kg), administration of PP did not result in noticeable peripheral or central cholinergic side effects. Only after administration of 200 mg/kg, mice showed convulsions affecting the whole body followed by death. These results show that compounds present in G. vellosii stembark have anticholinesterase activity, and that they can revert cognitive deficits in a model of cholinergic hypofunction.
Description: p. 508–513.: il. p&b.
URI: http://sr-vmlxaph03:8080/jspui/handle/123456789/5519
ISSN: 1873-5177
Appears in Collections:Artigos de Periódicos da área de Farmácia



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.